Your browser doesn't support javascript.
loading
Growth charts in Cockayne syndrome type 1 and type 2.
Baer, Sarah; Tuzin, Nicolas; Kang, Peter B; Mohammed, Shehla; Kubota, Masaya; van Ierland, Yvette; Busa, Tiffany; Rossi, Massimiliano; Morel, Godelieve; Michot, Caroline; Baujat, Geneviève; Durand, Myriam; Obringer, Cathy; Le May, Nicolas; Calmels, Nadège; Laugel, Vincent.
Affiliation
  • Baer S; Service de Pédiatrie 1, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Electronic address: sarah.baer@chru-strasbourg.fr.
  • Tuzin N; Groupe Méthode en Recherche Clinique, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, Strasbourg, France.
  • Kang PB; Division of Pediatric Neurology, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, 32610, USA.
  • Mohammed S; South East Thames Regional Genetics Service, Guy's and St Thomas' Hospital, Great Maze Pond, London, SE1 9RT, UK.
  • Kubota M; Division of Neurology, National Center for Child Health and Development, Tokyo, Japan.
  • van Ierland Y; Erasmus University Medical Center, Department of Clinical Genetics, 3000 CA Rotterdam, The Netherlands; ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, Rotterdam, The Netherlands.
  • Busa T; Hôpital de la Timone, Medical Genetics, Marseille, Provence-Alpes-Côte d'Azur, France.
  • Rossi M; Centre de référence des anomalies du développement, Service de génétique, Hospices Civils de Lyon & Centre de Recherche en Neurosciences de Lyon, Inserm U1028, UMR CNRS 5292, GENDEV Team, Lyon 1-Claude Bernard University, Bron, France.
  • Morel G; Service de Génétique Clinique, Centre de Référence Maladies Rares Centre Labellisé Anomalies du Développement-Ouest, Centre Hospitalier Universitaire de Rennes, 35033, Rennes, France.
  • Michot C; Service de génétique clinique, CRMR maladies osseuses constitutionnelles, INSERM UMR 1163, Université Paris-Descartes-Sorbonne Paris Cité, Institut Imagine, Hôpital Necker Enfants Malades, Paris, France.
  • Baujat G; Service de génétique clinique, CRMR maladies osseuses constitutionnelles, INSERM UMR 1163, Université Paris-Descartes-Sorbonne Paris Cité, Institut Imagine, Hôpital Necker Enfants Malades, Paris, France.
  • Durand M; Centre d'Investigation Clinique INSERM-CIC 1434, CHRU de Strasbourg, F - 67091, Strasbourg, France.
  • Obringer C; Laboratoire de Génétique médicale, INSERM U1112, Institut de génétique médicale d'Alsace, Faculté de Médecine de Strasbourg, Hôpitaux Universitaires de Strasbourg, France.
  • Le May N; Laboratoire de Génétique médicale, INSERM U1112, Institut de génétique médicale d'Alsace, Faculté de Médecine de Strasbourg, Hôpitaux Universitaires de Strasbourg, France.
  • Calmels N; Laboratoire de Génétique médicale, INSERM U1112, Institut de génétique médicale d'Alsace, Faculté de Médecine de Strasbourg, Hôpitaux Universitaires de Strasbourg, France; Laboratoires de Diagnostic Génétique, Institut de génétique médicale d'Alsace, Nouvel Hôpital Civil, Hôpitaux Universitaires de
  • Laugel V; Service de Pédiatrie 1, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Laboratoire de Génétique médicale, INSERM U1112, Institut de génétique médicale d'Alsace, Faculté de Médecine de Strasbourg, Hôpitaux Universitaires de Strasbourg, France.
Eur J Med Genet ; 64(1): 104105, 2021 Jan.
Article in En | MEDLINE | ID: mdl-33227433
Cockayne syndrome (CS) is a multisystem degenerative disorder divided in 3 overlapping subtypes, with a continuous phenotypic spectrum: CS2 being the most severe form, CS1 the classical form and CS3 the late-onset form. Failure to thrive and growth difficulties are among the most consistent features of CS, leaving affected individuals vulnerable to numerous medical complications, including adverse effects of undernutrition, abrupt overhydration and overfeeding. There is thus a significant need for specific growth charts. We retrospectively collected growth parameters from genetically-confirmed CS1 and CS2 patients, used the GAMLSS package to construct specific CS growth charts compared to healthy children from WHO and CDC databases. Growth data were obtained from 88 CS patients with a total of 1626 individual growth data points. 49 patients were classified as CS1 and 39 as CS2 with confirmed mutations in CSB/ERCC6, CSA/ERCC8 or ERCC1 genes. Individuals with CS1 initially have normal growth parameters; microcephaly occurs from 2 months whereas onset of weight and height restrictions appear later, between 5 and 22 months. In CS2, growth parameters are already below standard references at birth or drop below the 5th percentile before 3 months. Microcephaly is the first parameter to show a delay, appearing around 2 months in CS1 and at birth in CS2. Height and head circumference are more severely affected in CS2 compared to CS1 whereas weight curves are similar in CS1 and CS2 patients. These new growth charts will serve as a practical tool to improve the nutritional management of children with CS.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Body Height / Cockayne Syndrome / Growth Charts Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Eur J Med Genet Journal subject: GENETICA MEDICA Year: 2021 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Body Height / Cockayne Syndrome / Growth Charts Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Eur J Med Genet Journal subject: GENETICA MEDICA Year: 2021 Document type: Article Country of publication: Netherlands